Current treatment projects
Much of our treatment funding is concentrated in two long term commitments - to Dr Nicholas Goulden for the national MRD trials and to Dr Owen Williams for his work on infant leukaemia.
We are also funding a number of other treatment research projects across the UK. Click on any of the projects below for further information.
If you would like to read more about treatment projects that we have funded in the past, click here.
Dr Nicholas Goulden, Great Ormond Street Hospital
.jpg "Dr. Nicholas Goulden")
UK studies of minimal residual disease-based stratification and treatment of childhood acute lymphoblastic leukaemia (ALL)
Dr Nicholas Goulden, Great Ormond Street Hospital for Children; Dr Jeremy Hancock, University of Bristol; Professor Ajay Vora, Sheffield Children’s Hospital.
Award amount: £2,732,803
Date of award: March 2002
Read more about Dr Nicholas Goulden, Great Ormond Street HospitalDr Owen Williams, Institute of Child Health, London
.jpg "Dr Owen Williams")
The role of MLL in the molecular pathogenesis of infant and childhood leukaemia
Dr Owen Williams, Institute of Child Health, London
Award amount: £1,761,290
Date of award: December 2003
Read more about Dr Owen Williams, Institute of Child Health, LondonUK Children’s Cancer and Leukaemia Group
Clinical trial infrastructure support
Award amount: £600,000
Date of award: July 2007
Read more about UK Children’s Cancer and Leukaemia GroupProfessor Andrew Hall, University of Newcastle upon Tyne
.jpg "Professor Andrew Hall")
Drug resistance in children with acute lymphoblastic leukaemia
Award amount: £284,086
Date of award: December 2006
Read more about Professor Andrew Hall, University of Newcastle upon TyneDonate Online
Run for us
